- Lobbying
- Lobbying by Alkeus Pharmaceuticals, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Anna Abram | Dpty Comm, Pol, Leg, Intnl Affrs, FDA, Mar19Jan21; Mar17Mar19; Spcl Asst HHS, Jan21Mar17; Dec09Jan21; Hlth Dirctr, Sen Burr, Sen Hlth, L&P Comm, Apr09Dec09; Stff Mbr, Sen VA Comm, Feb09Apr09; AsstDrctr, WH Jan0709; LA, LC, SA, SenSantorum, May03Dec06 |
Virgil Miller | Policy Fellow, Rep. Edolphus Towns, Aug06 - Feb07; Prof Staff Mber, Commit on Eng and Com, Feb 07 - Jan 11; Health Policy Advisor, Rep. John D. Dingell, Jan 09 - Jan 11; CoS, Rep. Cedric Richmond, Jan 11 - Mar 19 |
Mia Heck | Confidential Asst. to Asst. Sec Pub. Affairs, ASPA, HHS (9/02 - 3/04); Dir. Special Proj., IOS, HHS (1/05 - 2/06); Snr Adv. to Administrator, CMS, HHS (10/17 - 1/18); Snr Adv., IEA, HHS (1/18 - 6/19); Dir. External Affairs, OASH, HSS (6/19-1/21) |
Sean Feely | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Registration
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate